If your email program has trouble displaying this email, view as a webpage. FDA's Generic Drug Program in 2020 Helped Ensure Availability of High-Quality, Affordable Drugs Amid COVID-19 Generic drugs play a vital role in facilitating access to lifesaving medicines for Americans and remain a public health priority for the U.S. Food and Drug Administration. Right now, there are more than 10,000 FDA-approved generic drugs and nine out of 10 prescriptions in the U.S. are filled by generics. Generic drugs have saved the health care system close to $2.2 trillion dollars in the past decade. That is good news for the health of Americans. Amid the challenges of a worldwide pandemic and rapidly advancing science, the FDA's generic drug program continued steadfast efforts to help increase the availability of safe, effective, high-quality, more affordable drugs in the U.S. Altogether in 2020, the FDA's generic drug program moved steadily forward even as the COVID-19 pandemic presented additional complexities, resulting in new realities and unique challenges.

Stay Connected with U.S. Food and Drug Administration:

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA